VivoSeq
Other

Intravenous

0

Pipeline Programs↗

34

Active Trials↗

81

Companies Involved↗

Intravenous is an early-stage landscape with 0 programs across 81 companies. The most active players are GSK, AstraZeneca, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

43/100

Pipeline Velocity

39/100

Mech. Concentration

N/A

Completion Rate

90/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalUCB logo

UCB

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

544

clinical trials

Completed420 · 77%
Unknown status38 · 7%
Terminated32 · 6%
Recruiting16 · 3%
Withdrawn11 · 2%
Active, not recruiting8 · 1%
Other19 · 3%

Clinical Trials

Trial Activity

544 trials

Subcutaneous Piperacillin/Tazobactam Compared With Intravenous Treatment
Recruiting·AAzienda Sanitaria Universitaria Friuli Centrale·Phase 2·NCT07481539·240 enrolled
Intranasal Versus Intravenous Fentanyl For Procedural Analgesia in Preterm Neonates
Recruiting·—·Phase 1·NCT07190625·75 enrolled
Perioperative Intravenous Nimodipine Trial
Recruiting·UUniversity of Ioannina·N/A·NCT07048522·40 enrolled
Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants
Recruiting·AAltruBio Inc.·Phase 1·NCT07350577·24 enrolled
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Recruiting·BBelgian Inflammatory Bowel Disease Research and Development (BIRD) VZW·Phase 4·NCT06113913·275 enrolled
A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
Recruiting·AbbVie logoAbbVie·Phase 1·NCT07413133·40 enrolled
A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT06812494·200 enrolled
Study of Intravenous ZMA001 in Healthy Subjects
Recruiting·National Heart, Lung, and Blood Institute (NHLBI)·Phase 1·NCT05967299·96 enrolled
Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
Recruiting·TThe Children's Hospital of Zhejiang University School of Medicine·N/A·NCT07113808·108 enrolled
Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients
Recruiting·IInstitute of Oncology Ljubljana·N/A·NCT07422792·40 enrolled
Effects Of Intravenous Oxytocin On Peripheral Sensory Afferents Using Microneurography
Recruiting·WWake Forest University Health Sciences·Phase 2·NCT07409753·60 enrolled
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
Recruiting·UUniversity Hospital, Basel, Switzerland·Phase 1·NCT07444788·40 enrolled
Ketorolac Intravenous Regional Analgesia in Lower Limb Surgeries
Recruiting·MMansoura University·N/A·NCT05543785·76 enrolled
Intravenous Iron Effects on Performance at High Altitude
Recruiting·—·Phase 4·NCT06686693·24 enrolled
Intravenous Hydromorphone for the Treatment of Acute Pain
Recruiting·TThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School·Phase 1/2·NCT06949059·30 enrolled
Page 1 of 37

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)